Carcinoma
MONDO:0004993A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.
Also known as: epithelioma, Other carcinoma, carcinoma, carcinoma, malignant, epithelial carcinoma, epithelioma malignant, malignant epithelial neoplasm, malignant epithelial tumor
16928 clinical trials for this condition and its sub-types, 224 tagged with Carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Carcinoma
-
Adenocarcinoma 184 trials · 5,243 incl. sub-types
64 sub-types
- Hepatocellular carcinoma 1,043 trials · 1,088 incl. sub-types Sub-types →
- Pancreatic adenocarcinoma 493 trials · 926 incl. sub-types Sub-types →
- Renal cell carcinoma 611 trials · 710 incl. sub-types Sub-types →
- Tubular adenocarcinoma 0 trials · 557 incl. sub-types Sub-types →
- Colorectal adenocarcinoma 246 trials · 546 incl. sub-types Sub-types →
- Gastroesophageal junction adenocarcinoma 506 trials
- Gastric adenocarcinoma 448 trials · 480 incl. sub-types Sub-types →
- Bile duct adenocarcinoma 17 trials · 416 incl. sub-types Sub-types →
- Prostate adenocarcinoma 297 trials Sub-types →
- Breast adenocarcinoma 36 trials · 278 incl. sub-types Sub-types →
- Serous adenocarcinoma 6 trials · 241 incl. sub-types Sub-types →
- Ovarian adenocarcinoma 12 trials · 230 incl. sub-types Sub-types →
- Clear cell adenocarcinoma 14 trials · 201 incl. sub-types Sub-types →
- Esophageal adenocarcinoma 168 trials · 172 incl. sub-types Sub-types →
- Adenocarcinoma in situ 10 trials · 170 incl. sub-types Sub-types →
- Endometrioid adenocarcinoma 12 trials · 144 incl. sub-types Sub-types →
- Endometrium adenocarcinoma 30 trials · 118 incl. sub-types Sub-types →
- Thyroid gland adenocarcinoma 0 trials · 118 incl. sub-types Sub-types →
- Lung adenocarcinoma 114 trials · 117 incl. sub-types Sub-types →
- Gastroesophageal adenocarcinoma 93 trials
- Papillary adenocarcinoma 2 trials · 92 incl. sub-types Sub-types →
- Fallopian tube adenocarcinoma 4 trials · 81 incl. sub-types Sub-types →
- Small intestine adenocarcinoma 18 trials · 60 incl. sub-types Sub-types →
- Mucinous adenocarcinoma 18 trials · 57 incl. sub-types Sub-types →
- Adenoid cystic carcinoma 46 trials · 47 incl. sub-types Sub-types →
- Cervical adenocarcinoma 27 trials · 34 incl. sub-types Sub-types →
- Poorly differentiated thyroid gland carcinoma 17 trials
- Acinar cell carcinoma 4 trials · 15 incl. sub-types Sub-types →
- Signet ring cell carcinoma 4 trials · 11 incl. sub-types Sub-types →
- Paget disease 2 trials · 9 incl. sub-types Sub-types →
- Gallbladder adenocarcinoma 9 trials Sub-types →
- Bladder adenocarcinoma 5 trials · 8 incl. sub-types Sub-types →
- Vaginal adenocarcinoma 7 trials Sub-types →
- Cystadenocarcinoma 0 trials · 6 incl. sub-types Sub-types →
- Diffuse type adenocarcinoma 1 trial · 6 incl. sub-types Sub-types →
- Vulvar adenocarcinoma 3 trials · 5 incl. sub-types Sub-types →
- Parathyroid gland carcinoma 4 trials
- Pituitary adenocarcinoma 3 trials Sub-types →
- Sebaceous adenocarcinoma 2 trials · 3 incl. sub-types Sub-types →
- Hepatoid adenocarcinoma 2 trials Sub-types →
- Mesonephric adenocarcinoma 2 trials Sub-types →
- Sweat gland carcinoma 1 trial · 2 incl. sub-types Sub-types →
- Urethra adenocarcinoma 1 trial · 2 incl. sub-types Sub-types →
- Follicular variant thyroid gland papillary carcinoma 1 trial
- Micropapillary serous carcinoma 1 trial
- Nasal cavity adenocarcinoma 1 trial
- Seminal vesicle adenocarcinoma 1 trial
- Trabecular adenocarcinoma 1 trial
- Ureter adenocarcinoma 1 trial
- Adenoacanthoma 0 trials
- Epididymal adenocarcinoma 0 trials
- Ethmoid sinus adenocarcinoma 0 trials
- Granular cell carcinoma 0 trials
- Intestinal type adenocarcinoma 0 trials Sub-types →
- Lacrimal gland adenocarcinoma 0 trials Sub-types →
- Maxillary sinus adenocarcinoma 0 trials
- Middle ear adenocarcinoma 0 trials
- Minor salivary gland adenocarcinoma 0 trials Sub-types →
- Rete testis adenocarcinoma 0 trials
- Salivary gland basal cell adenocarcinoma 0 trials
- Scirrhous adenocarcinoma 0 trials
- Submandibular gland adenocarcinoma 0 trials
- Thymus gland adenocarcinoma 0 trials Sub-types →
- Villous adenocarcinoma 0 trials Sub-types →
-
Digestive system carcinoma 25 trials · 4,876 incl. sub-types
16 sub-types
- Carcinoma of liver and intrahepatic biliary tract 36 trials · 1,455 incl. sub-types Sub-types →
- Colorectal carcinoma 305 trials · 1,166 incl. sub-types Sub-types →
- Exocrine pancreatic carcinoma 205 trials · 1,033 incl. sub-types Sub-types →
- Gastric carcinoma 92 trials · 554 incl. sub-types Sub-types →
- Gastroesophageal junction adenocarcinoma 506 trials
- Carcinoma of esophagus 75 trials · 504 incl. sub-types Sub-types →
- Carcinoma of pharynx 3 trials · 455 incl. sub-types Sub-types →
- Oral cavity carcinoma 16 trials · 200 incl. sub-types Sub-types →
- Small intestine carcinoma 19 trials · 105 incl. sub-types Sub-types →
- Gallbladder carcinoma 40 trials · 48 incl. sub-types Sub-types →
- Intestine carcinoma in situ 0 trials · 16 incl. sub-types Sub-types →
- Pancreatic endocrine carcinoma 12 trials Sub-types →
- Digestive system mixed adenoneuroendocrine carcinoma 0 trials · 3 incl. sub-types Sub-types →
- Carcinoma of floor of mouth 1 trial · 2 incl. sub-types Sub-types →
- Maxillary sinus carcinoma 1 trial · 2 incl. sub-types Sub-types →
- Ameloblastic carcinoma 0 trials
-
Lung carcinoma 137 trials · 3,320 incl. sub-types
10 sub-types
- Non-small cell lung carcinoma 2,721 trials · 2,834 incl. sub-types Sub-types →
- Small cell lung carcinoma 514 trials · 515 incl. sub-types Sub-types →
- Squamous cell lung carcinoma 65 trials · 145 incl. sub-types Sub-types →
- Bronchogenic carcinoma 25 trials Sub-types →
- Lung carcinoma in situ 2 trials · 3 incl. sub-types Sub-types →
- Combined lung carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Asbestos-related lung carcinoma 0 trials
- Lung epithelial-myoepithelial carcinoma 0 trials
- Lung hilum carcinoma 0 trials
- Lung inflammatory myofibroblastic tumor 0 trials
-
Breast carcinoma 665 trials · 2,688 incl. sub-types
13 sub-types
- Breast carcinoma by gene expression profile 0 trials · 1,787 incl. sub-types Sub-types →
- Invasive breast carcinoma 324 trials · 412 incl. sub-types Sub-types →
- Breast adenocarcinoma 36 trials · 278 incl. sub-types Sub-types →
- Breast carcinoma in situ 76 trials · 204 incl. sub-types Sub-types →
- Female breast carcinoma 137 trials Sub-types →
- Male breast carcinoma 22 trials
- Hereditary breast carcinoma 10 trials Sub-types →
- Bilateral breast carcinoma 6 trials · 9 incl. sub-types Sub-types →
- Hormone-resistant breast carcinoma 5 trials
- Sporadic breast cancer 2 trials
- Ehrlich tumor carcinoma 0 trials
- Cribriform carcinoma of breast 0 trials Sub-types →
- Nipple carcinoma 0 trials Sub-types →
-
Squamous cell carcinoma 177 trials · 1,766 incl. sub-types
39 sub-types
- Head and neck squamous cell carcinoma 829 trials · 1,053 incl. sub-types Sub-types →
- Esophageal squamous cell carcinoma 303 trials · 304 incl. sub-types Sub-types →
- Skin squamous cell carcinoma 149 trials · 156 incl. sub-types Sub-types →
- Squamous cell lung carcinoma 65 trials · 145 incl. sub-types Sub-types →
- Human papillomavirus-related squamous cell carcinoma 115 trials · 116 incl. sub-types Sub-types →
- Colorectal squamous cell carcinoma 1 trial · 54 incl. sub-types Sub-types →
- Adenosquamous carcinoma 8 trials · 45 incl. sub-types Sub-types →
- Cervical squamous cell carcinoma 36 trials · 40 incl. sub-types Sub-types →
- Metastatic squamous cell carcinoma 39 trials
- Squamous cell carcinoma of penis 21 trials · 29 incl. sub-types Sub-types →
- Vulvar squamous cell carcinoma 22 trials Sub-types →
- Squamous cell carcinoma of pancreas 3 trials · 13 incl. sub-types Sub-types →
- Bone squamous cell carcinoma 0 trials · 11 incl. sub-types Sub-types →
- Squamous carcinoma in situ 5 trials · 10 incl. sub-types Sub-types →
- Vaginal squamous cell carcinoma 8 trials
- Basaloid squamous cell carcinoma 2 trials · 5 incl. sub-types Sub-types →
- Bladder squamous cell carcinoma 5 trials Sub-types →
- Gastric squamous cell carcinoma 4 trials Sub-types →
- Papillary squamous carcinoma 1 trial · 4 incl. sub-types Sub-types →
- Thyroid gland squamous cell carcinoma 4 trials
- Endometrial squamous cell carcinoma 0 trials · 2 incl. sub-types Sub-types →
- Ovarian squamous cell carcinoma 2 trials
- Urethra squamous cell carcinoma 2 trials Sub-types →
- Keratinizing squamous cell carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Pure squamous carcinoma of the urothelial tract 1 trial
- Scrotum squamous cell carcinoma 1 trial
- Squamous cell carcinoma of the small intestine 1 trial Sub-types →
- Ureter squamous cell carcinoma 1 trial
- Fallopian tube squamous cell carcinoma 0 trials
- Gallbladder squamous cell carcinoma 0 trials Sub-types →
- Prostate squamous cell carcinoma 0 trials Sub-types →
- Pseudoglandular squamous cell carcinoma 0 trials
- Renal pelvis squamous cell carcinoma 0 trials
- Sarcomatoid squamous cell carcinoma 0 trials Sub-types →
- Squamous cell breast carcinoma 0 trials Sub-types →
- Squamous cell carcinoma of liver and intrahepatic biliary tract 0 trials Sub-types →
- Squamous cell carcinoma of the corpus uteri 0 trials
- Thymus squamous cell carcinoma 0 trials Sub-types →
- Trachea squamous cell carcinoma 0 trials Sub-types →
-
Head and neck carcinoma 73 trials · 1,415 incl. sub-types
16 sub-types
- Head and neck squamous cell carcinoma 829 trials · 1,053 incl. sub-types Sub-types →
- Lip and oral cavity carcinoma 94 trials · 258 incl. sub-types Sub-types →
- Oropharyngeal carcinoma 99 trials · 242 incl. sub-types Sub-types →
- Nasopharyngeal carcinoma 210 trials · 211 incl. sub-types Sub-types →
- Hypopharyngeal carcinoma 35 trials · 86 incl. sub-types Sub-types →
- Nasal cavity and paranasal sinus carcinoma 21 trials · 44 incl. sub-types Sub-types →
- Nasal cavity carcinoma 3 trials · 9 incl. sub-types Sub-types →
- Eye carcinoma 0 trials · 5 incl. sub-types Sub-types →
- Pituitary adenocarcinoma 3 trials Sub-types →
- Carcinoma of floor of mouth 1 trial · 2 incl. sub-types Sub-types →
- External ear carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Middle ear carcinoma 1 trial Sub-types →
- Ameloblastic carcinoma 0 trials
- Growth hormone-producing pituitary gland carcinoma 0 trials
- Laryngeal small cell carcinoma 0 trials
- Pharyngeal adenoid cystic carcinoma 0 trials
-
Prostate carcinoma 394 trials · 1,321 incl. sub-types
9 sub-types
- Metastatic prostate carcinoma 670 trials
- Castration-resistant prostate carcinoma 478 trials
- Prostate adenocarcinoma 297 trials Sub-types →
- Hormone-resistant prostate carcinoma 30 trials
- Prostate small cell carcinoma 9 trials
- Familial prostate carcinoma 0 trials
- Grade III prostatic intraepithelial neoplasia 0 trials
- Primary prostate urothelial carcinoma 0 trials Sub-types →
- Prostate squamous cell carcinoma 0 trials Sub-types →
-
Renal carcinoma 85 trials · 764 incl. sub-types
3 sub-types
- Renal cell carcinoma 611 trials · 710 incl. sub-types Sub-types →
- Renal pelvis carcinoma 15 trials · 22 incl. sub-types Sub-types →
- Kidney carcinoma in situ 0 trials Sub-types →
-
Neuroendocrine carcinoma 106 trials · 744 incl. sub-types
12 sub-types
- Small cell carcinoma 26 trials · 542 incl. sub-types Sub-types →
- Cutaneous neuroendocrine carcinoma 78 trials
- Medullary thyroid gland carcinoma 42 trials · 53 incl. sub-types Sub-types →
- Large cell neuroendocrine carcinoma 12 trials · 31 incl. sub-types Sub-types →
- Pancreatic endocrine carcinoma 12 trials Sub-types →
- Malignant adrenal gland pheochromocytoma 11 trials
- Liver neuroendocrine carcinoma 3 trials Sub-types →
- Thymic neuroendocrine carcinoma 3 trials Sub-types →
- Goblet cell carcinoma 2 trials
- Anal canal neuroendocrine neoplasm 1 trial Sub-types →
- Combined lung carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Vulvar neuroendocrine carcinoma 0 trials Sub-types →
-
Transitional cell carcinoma 249 trials · 721 incl. sub-types
9 sub-types
- Urothelial carcinoma 363 trials · 692 incl. sub-types Sub-types →
- Fallopian tube transitional cell carcinoma 12 trials
- Ovarian transitional cell carcinoma 12 trials
- Papillary transitional cell carcinoma 1 trial · 11 incl. sub-types Sub-types →
- Sarcomatoid transitional cell carcinoma 0 trials · 5 incl. sub-types Sub-types →
- Bartholin gland transitional cell carcinoma 1 trial
- Endometrial transitional cell carcinoma 1 trial
- Primary prostate urothelial carcinoma 0 trials Sub-types →
- Transitional cell carcinoma of the corpus uteri 0 trials
-
Urinary bladder carcinoma 392 trials · 669 incl. sub-types
9 sub-types
- Bladder transitional cell carcinoma 130 trials · 408 incl. sub-types Sub-types →
- Superficial urinary bladder carcinoma 76 trials
- Stage IVb bladder cancer 39 trials
- Urinary bladder small cell neuroendocrine carcinoma 9 trials
- Bladder adenocarcinoma 5 trials · 8 incl. sub-types Sub-types →
- Bladder urachal carcinoma 3 trials · 6 incl. sub-types Sub-types →
- Bladder squamous cell carcinoma 5 trials Sub-types →
- Bladder small cell carcinoma 0 trials
- Childhood bladder carcinoma 0 trials
-
Malignant epithelial tumor of ovary 8 trials · 656 incl. sub-types
6 sub-types
- Ovarian carcinoma 493 trials · 642 incl. sub-types Sub-types →
- Malignant ovarian serous tumor 5 trials · 202 incl. sub-types Sub-types →
- Ovarian endometrial cancer 4 trials · 88 incl. sub-types Sub-types →
- Ovarian clear cell cancer 30 trials · 51 incl. sub-types Sub-types →
- Mucinous ovarian cancer 2 trials · 16 incl. sub-types Sub-types →
- Malignant ovarian Brenner tumor 2 trials
-
Uterine carcinoma 3 trials · 611 incl. sub-types
9 sub-types
- Cervical carcinoma 257 trials · 317 incl. sub-types Sub-types →
- Endometrial carcinoma 207 trials · 313 incl. sub-types Sub-types →
- Endometrial serous adenocarcinoma 36 trials
- Uterus carcinoma in situ 0 trials · 16 incl. sub-types Sub-types →
- Adenoid cystic carcinoma of the corpus uteri 0 trials
- Papillary carcinoma of the corpus uteri 0 trials
- Squamous cell carcinoma of the corpus uteri 0 trials
- Transitional cell carcinoma of the corpus uteri 0 trials
- Undifferentiated carcinoma of the corpus uteri 0 trials
-
Invasive carcinoma 4 trials · 604 incl. sub-types
4 sub-types
- Invasive breast carcinoma 324 trials · 412 incl. sub-types Sub-types →
- Infiltrating urothelial carcinoma 5 trials · 185 incl. sub-types Sub-types →
- Invasive malignant thymoma 4 trials
- Submucosal invasive colon adenocarcinoma 0 trials
-
Peritoneal carcinoma 16 trials · 389 incl. sub-types
3 sub-types
- Primary peritoneal carcinoma 351 trials · 361 incl. sub-types Sub-types →
- Peritoneal serous adenocarcinoma 2 trials · 39 incl. sub-types Sub-types →
- Pseudomyxoma peritonei 17 trials
-
In situ carcinoma 25 trials · 318 incl. sub-types
21 sub-types
- Breast carcinoma in situ 76 trials · 204 incl. sub-types Sub-types →
- Adenocarcinoma in situ 10 trials · 170 incl. sub-types Sub-types →
- Bladder carcinoma in situ 30 trials
- Intestine carcinoma in situ 0 trials · 16 incl. sub-types Sub-types →
- Uterus carcinoma in situ 0 trials · 16 incl. sub-types Sub-types →
- Esophagus carcinoma in situ 13 trials
- Squamous carcinoma in situ 5 trials · 10 incl. sub-types Sub-types →
- Skin carcinoma in situ 3 trials · 9 incl. sub-types Sub-types →
- Oral cavity carcinoma in situ 5 trials Sub-types →
- Stomach carcinoma in situ 4 trials Sub-types →
- Lung carcinoma in situ 2 trials · 3 incl. sub-types Sub-types →
- Pharynx carcinoma in situ 0 trials · 2 incl. sub-types Sub-types →
- Larynx carcinoma in situ 1 trial Sub-types →
- Carcinoma in situ of ureter 0 trials
- Carcinoma in situ of urethra 0 trials
- Eye carcinoma in situ 0 trials
- Gall bladder carcinoma in situ 0 trials
- Grade III prostatic intraepithelial neoplasia 0 trials
- Kidney carcinoma in situ 0 trials Sub-types →
- Liver carcinoma in situ 0 trials Sub-types →
- Nasal cavity carcinoma in situ 0 trials
-
Skin carcinoma 34 trials · 281 incl. sub-types
13 sub-types
- Skin squamous cell carcinoma 149 trials · 156 incl. sub-types Sub-types →
- Cutaneous neuroendocrine carcinoma 78 trials
- Skin basal cell carcinoma 51 trials · 59 incl. sub-types Sub-types →
- Skin carcinoma in situ 3 trials · 9 incl. sub-types Sub-types →
- Anal margin carcinoma 1 trial · 6 incl. sub-types Sub-types →
- Skin appendage carcinoma 4 trials · 6 incl. sub-types Sub-types →
- Eyelid carcinoma 1 trial · 2 incl. sub-types Sub-types →
- Cutaneous Paget disease 0 trials · 1 incl. sub-types Sub-types →
- Borst-Jadassohn intraepidermal carcinoma 0 trials
- Cutaneous mucoepidermoid carcinoma 0 trials
- Labia majora carcinoma 0 trials
- Labia minora carcinoma 0 trials
- Vulvar seborrheic keratosis 0 trials Sub-types →
-
Thyroid gland carcinoma 41 trials · 237 incl. sub-types
11 sub-types
- Differentiated thyroid carcinoma 79 trials · 182 incl. sub-types Sub-types →
- Thyroid gland adenocarcinoma 0 trials · 118 incl. sub-types Sub-types →
- Thyroid gland undifferentiated (anaplastic) carcinoma 35 trials
- Multiple endocrine neoplasia type 2 4 trials · 30 incl. sub-types Sub-types →
- Familial nonmedullary thyroid carcinoma 3 trials · 15 incl. sub-types Sub-types →
- Thyroid gland squamous cell carcinoma 4 trials
- Intrathyroid thymic carcinoma 0 trials
- Thyroid gland cribriform morular carcinoma 0 trials
- Thyroid gland mixed medullary and follicular cell-derived carcinoma 0 trials
- Thyroid gland mucinous carcinoma 0 trials
- Thyroid gland spindle cell tumor with thymus-like differentiation 0 trials
-
Fallopian tube carcinoma 126 trials · 182 incl. sub-types
6 sub-types
- Fallopian tube adenocarcinoma 4 trials · 81 incl. sub-types Sub-types →
- Fallopian tube transitional cell carcinoma 12 trials
- Fallopian tube carcinosarcoma 8 trials
- Fallopian tube gestational choriocarcinoma 0 trials
- Fallopian tube squamous cell carcinoma 0 trials
- Hereditary fallopian tube carcinoma 0 trials
-
Secondary carcinoma 1 trial · 169 incl. sub-types
1 sub-type
- Metastatic carcinoma 22 trials · 168 incl. sub-types Sub-types →
-
Bone carcinoma 0 trials · 131 incl. sub-types
7 sub-types
- Metastatic carcinoma in the bone 107 trials
- Paranasal sinus carcinoma 4 trials · 21 incl. sub-types Sub-types →
- Bone squamous cell carcinoma 0 trials · 11 incl. sub-types Sub-types →
- Pituitary adenocarcinoma 3 trials Sub-types →
- Adamantinoma 0 trials Sub-types →
- Growth hormone-producing pituitary gland carcinoma 0 trials
- Osteosarcoma arising in bone Paget disease 0 trials
-
Basal cell carcinoma 111 trials · 120 incl. sub-types
1 sub-type
- Skin basal cell carcinoma 51 trials · 59 incl. sub-types Sub-types →
-
Laryngeal carcinoma 56 trials · 114 incl. sub-types
8 sub-types
- Laryngeal squamous cell carcinoma 72 trials · 77 incl. sub-types Sub-types →
- Glottis carcinoma 6 trials · 10 incl. sub-types Sub-types →
- Carcinoma of supraglottis 1 trial · 2 incl. sub-types Sub-types →
- Larynx carcinoma in situ 1 trial Sub-types →
- Subglottis carcinoma 1 trial Sub-types →
- Laryngeal adenoid cystic carcinoma 0 trials
- Laryngeal mucoepidermoid carcinoma 0 trials
- Laryngeal small cell carcinoma 0 trials
-
Papillary carcinoma 8 trials · 112 incl. sub-types
5 sub-types
- Papillary adenocarcinoma 2 trials · 92 incl. sub-types Sub-types →
- Papillary transitional cell carcinoma 1 trial · 11 incl. sub-types Sub-types →
- Papillary squamous carcinoma 1 trial · 4 incl. sub-types Sub-types →
- Papillary carcinoma of the cervix uteri 0 trials Sub-types →
- Papillary carcinoma of the corpus uteri 0 trials
-
Large cell carcinoma 2 trials · 87 incl. sub-types
5 sub-types
- Lung large cell carcinoma 11 trials · 37 incl. sub-types Sub-types →
- Thyroid gland undifferentiated (anaplastic) carcinoma 35 trials
- Large cell neuroendocrine carcinoma 12 trials · 31 incl. sub-types Sub-types →
- Nasopharyngeal type undifferentiated carcinoma 2 trials · 3 incl. sub-types Sub-types →
- Salivary gland large cell carcinoma 0 trials
-
Undifferentiated carcinoma 6 trials · 80 incl. sub-types
14 sub-types
- Thyroid gland undifferentiated (anaplastic) carcinoma 35 trials
- Undifferentiated ovarian carcinoma 13 trials
- Endometrial undifferentiated carcinoma 9 trials
- Undifferentiated carcinoma of nasopharynx 7 trials
- Nut midline carcinoma 6 trials
- Sinonasal undifferentiated carcinoma 6 trials
- Undifferentiated carcinoma of esophagus 1 trial
- Undifferentiated carcinoma of liver and intrahepatic biliary tract 1 trial
- Undifferentiated carcinoma of stomach 1 trial
- Undifferentiated pancreatic carcinoma 1 trial Sub-types →
- Salivary gland large cell carcinoma 0 trials
- Thymic undifferentiated carcinoma 0 trials
- Undifferentiated carcinoma of the corpus uteri 0 trials
- Undifferentiated gallbladder carcinoma 0 trials
-
Mucin-producing carcinoma 0 trials · 58 incl. sub-types
2 sub-types
- Mucinous adenocarcinoma 18 trials · 57 incl. sub-types Sub-types →
- Pancreatic mucinous cystadenoma 1 trial
-
Retroperitoneum carcinoma 0 trials · 52 incl. sub-types
1 sub-type
- Adrenal carcinoma 34 trials · 52 incl. sub-types Sub-types →
-
Vulvar carcinoma 24 trials · 45 incl. sub-types
9 sub-types
- Vulvar squamous cell carcinoma 22 trials Sub-types →
- Vulvar adenocarcinoma 3 trials · 5 incl. sub-types Sub-types →
- Bartholin gland carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Clitoral carcinoma 0 trials
- Labia majora carcinoma 0 trials
- Labia minora carcinoma 0 trials
- Vulva basal cell carcinoma 0 trials
- Vulvar neuroendocrine carcinoma 0 trials Sub-types →
- Vulvar seborrheic keratosis 0 trials Sub-types →
-
Thymic carcinoma 41 trials · 44 incl. sub-types
9 sub-types
- Invasive malignant thymoma 4 trials
- Thymic neuroendocrine carcinoma 3 trials Sub-types →
- Lymphoepithelioma-like thymic carcinoma 0 trials
- Malignant type AB thymoma 0 trials
- Thymic sarcomatoid carcinoma 0 trials
- Thymic undifferentiated carcinoma 0 trials
- Thymus clear cell carcinoma 0 trials
- Thymus gland adenocarcinoma 0 trials Sub-types →
- Thymus squamous cell carcinoma 0 trials Sub-types →
-
Penile carcinoma 9 trials · 35 incl. sub-types
3 sub-types
- Squamous cell carcinoma of penis 21 trials · 29 incl. sub-types Sub-types →
- Paget disease of the penis 0 trials
- Penis basal cell carcinoma 0 trials
-
Sarcomatoid carcinoma 1 trial · 26 incl. sub-types
8 sub-types
- Sarcomatoid renal cell carcinoma 15 trials
- Lung sarcomatoid carcinoma 3 trials · 7 incl. sub-types Sub-types →
- Sarcomatoid transitional cell carcinoma 0 trials · 5 incl. sub-types Sub-types →
- Pleomorphic carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Rectal sarcomatoid carcinoma 0 trials
- Sarcomatoid basal cell carcinoma 0 trials
- Sarcomatoid squamous cell carcinoma 0 trials Sub-types →
- Thymic sarcomatoid carcinoma 0 trials
-
Vaginal carcinoma 12 trials · 22 incl. sub-types
2 sub-types
- Vaginal squamous cell carcinoma 8 trials
- Vaginal adenocarcinoma 7 trials Sub-types →
-
Carcinoma of urethra 2 trials · 21 incl. sub-types
5 sub-types
- Urethra transitional cell carcinoma 17 trials Sub-types →
- Urethra adenocarcinoma 1 trial · 2 incl. sub-types Sub-types →
- Urethra squamous cell carcinoma 2 trials Sub-types →
- Littre gland carcinoma 0 trials Sub-types →
- Carcinoma in situ of urethra 0 trials
-
Ureter carcinoma 1 trial · 19 incl. sub-types
6 sub-types
- Ureter transitional cell carcinoma 16 trials Sub-types →
- Ureter adenocarcinoma 1 trial
- Ureter small cell carcinoma 1 trial
- Ureter squamous cell carcinoma 1 trial
- Carcinoma in situ of ureter 0 trials
- Regional ureteric cancer 0 trials
-
Choroid plexus carcinoma 11 trials
1 sub-type
-
Basaloid carcinoma 0 trials · 5 incl. sub-types
2 sub-types
- Basaloid squamous cell carcinoma 2 trials · 5 incl. sub-types Sub-types →
- Basaloid large cell lung carcinoma 0 trials
-
Cribriform carcinoma 1 trial · 4 incl. sub-types
2 sub-types
- Salivary duct carcinoma 3 trials
- Cribriform carcinoma of breast 0 trials Sub-types →
-
Malignant myoepithelioma 2 trials
1 sub-type
- Malignant breast myoepithelioma 0 trials
-
Combined carcinoid and adenocarcinoma 0 trials · 2 incl. sub-types
1 sub-type
- Goblet cell carcinoma 2 trials
-
Carcinoma ex pleomorphic adenoma 1 trial
2 sub-types
-
Trachea carcinoma 1 trial
3 sub-types
- Trachea mucoepidermoid carcinoma 0 trials
- Trachea squamous cell carcinoma 0 trials Sub-types →
- Tracheal adenoid cystic carcinoma 0 trials
-
Scrotal carcinoma 0 trials · 1 incl. sub-types
3 sub-types
- Scrotum squamous cell carcinoma 1 trial
- Scrotum Paget disease 0 trials
- Scrotum basal cell carcinoma 0 trials
-
Krebs 2 carcinoma 0 trials
-
Comedocarcinoma 0 trials
-
Epithelial-myoepithelial carcinoma 0 trials
2 sub-types
-
Glycogen-rich carcinoma 0 trials
1 sub-type
-
Lipid-rich carcinoma 0 trials
1 sub-type
- Lipid-rich breast carcinoma 0 trials
-
Lymph node carcinoma 0 trials
Most studied deeper sub-types
-
Can a year of sunitinib delay kidney Cancer's return after lung surgery?
Disease control Stopped earlyThis phase 2 trial investigates whether taking the drug sunitinib for one year after surgical removal of lung metastases can improve relapse-free survival in patients with clear cell kidney cancer. Participants are randomly assigned to receive either sunitinib or a placebo follow…
Phase 2 • Sponsor: Association of Urologic Oncology (AUO) • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can a pill target Hard-to-Treat ovarian cancers?
Disease control Stopped earlyThis early-stage trial is testing an experimental oral drug called NXP800 in people with advanced solid tumors that have not responded to standard treatments. The study has two parts: first, to find the safest dose and schedule, and then to see if the drug shows promise in specif…
Phase 1 • Sponsor: Nuvectis Pharma, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a Two-Pronged attack shrink Hard-to-Treat cancers?
Disease control Stopped earlyThis trial tests whether an experimental drug called XNW5004, which blocks a protein that helps cancer grow, can boost the effects of the immunotherapy pembrolizumab (Keytruda) in people with advanced solid tumors that have stopped responding to standard treatments. The study inc…
Phase 1/2 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Targeted pill shows promise for rare lung cancer, but trial stopped early
Disease control Stopped earlyThis phase 3 study tested a new drug called pralsetinib against standard chemotherapy for people with a specific type of advanced lung cancer that has a RET gene fusion. The goal was to see if pralsetinib could better delay cancer growth. The trial was terminated early, so full r…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Experimental virus therapy VAXINIA tested in advanced cancer patients
Disease control Stopped earlyThis early-stage study tested a new treatment called VAXINIA (CF33-hNIS), a virus designed to attack cancer cells, in 66 adults with advanced solid tumors that had spread. The treatment was given alone or with the immunotherapy drug pembrolizumab, either as a shot into the tumor …
Phase 1 • Sponsor: Imugene Limited • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New cancer drug tested in people with advanced tumors
Disease control Stopped earlyThis early study tested a new drug called PHN-010 in 26 people with advanced cancers like lung, colon, and ovarian cancer. The drug is designed to deliver a powerful treatment directly to cancer cells. The main goals were to check safety and find the right dose, but the study was…
Phase 1 • Sponsor: Pheon Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Immune cells supercharged to fight ovarian cancer
Disease control Stopped earlyThis early-stage study tested a new way to treat ovarian, fallopian tube, or primary peritoneal cancer that had returned or stopped responding to standard treatments. Researchers took a type of white blood cell (monocytes) from each participant, stimulated them with two immune-bo…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Experimental gene therapy targets common cancer protein
Disease control Stopped earlyThis early-phase trial tested a new type of immunotherapy for people with advanced cancers that carry a specific protein called KK-LC-1. The treatment involved collecting a patient's own immune cells, modifying them in the lab to better recognize and attack cancer cells, and infu…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Kidney cancer combo trial halted early – what we know
Disease control Stopped earlyThis study tested a new drug (NKT2152) combined with two other medicines (palbociclib and sasanlimab) in people with advanced clear cell kidney cancer that had worsened after prior treatments. The goal was to see if the combination was safe and could shrink tumors. The trial was …
Phase 2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New PET scan could help doctors choose the right chemo for cancer patients
Diagnosis Stopped earlyThis early-phase trial is testing whether a new radioactive tracer called 18F-Clofarabine (CFA) can be used in PET scans to measure an enzyme activity in cancer cells that may predict how well certain drugs like gemcitabine work. Four adults with metastatic cancer will receive th…
Early phase 1 • Sponsor: Roberto Vargas • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC
-
New PET tracer could spot hidden brain tumors in cancer patients
Diagnosis Stopped earlyThis study tested a special radioactive tracer (68GaNOTA-Anti-HER2 VHH1) to see if it can find HER2-positive brain metastases on PET/CT scans. Seven adult cancer patients with at least one brain lesion were enrolled. The goal was to compare tracer uptake in HER2-positive versus H…
Phase 2 • Sponsor: Universitair Ziekenhuis Brussel • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New scanner aims to spot tiny tumors, but study stalls early
Diagnosis Stopped earlyThis study tested a new imaging technique called AWSM-PET/CT that adds a few minutes to a standard PET/CT scan to get clearer pictures of small cancer spots. Researchers planned to enroll cancer patients to see if the new method improved accuracy. However, the study was stopped e…
Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Virtual reality could help measure and treat cancer pain, study suggests
Knowledge-focused Stopped earlyThis study explored whether a wearable brain scanner (fNIRS) could objectively measure pain in cancer patients and survivors. It also tested if virtual reality (VR) relaxation could help reduce pain. The study included 106 participants, including healthy volunteers and cancer pat…
Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Ovarian cancer immune cells under microscope in terminated study
Knowledge-focused Stopped earlyThis study aimed to understand how immune cells in the blood, abdominal fluid, and tumor tissue change in women with advanced ovarian or fallopian tube cancer before and after chemotherapy. Researchers collected samples from 36 women to count different types of immune cells. The …
Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Kidney cancer drug safety checked in patients with poor kidney function
Knowledge-focused Stopped earlyThis study looked at the safety of the cancer drug nivolumab in people with metastatic kidney cancer who also have kidney failure. Researchers planned to compare side effects in 81 patients with different levels of kidney function. However, the study was terminated early, so the …
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:49 UTC